2:18 PM
Nov 14, 2017
 |  BC Extra  |  Preclinical News

Hybrid T cells show anticancer effects

A study published in Cell Metabolism by researchers at Medical University of South Carolina and colleagues showed that the enhanced antitumor effect of a hybrid of T helper types 1 (Th1) and 17 (Th17) cells was dependent on activity of sirtuin 1 (SIRT1) and reduced CD38 expression, suggesting new targets for developing antitumor adoptive T cell therapies.

Th17 cells show promise for cancer...

Read the full 300 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >